Biomarkers for Myocardial Infarction Type Discrimination-The Key Might Be in the Time Course of the Disease

Authors :: Ahmad Hayek
Thomas Bochaton
François Derimay
Hôpital Louis Pradel [CHU - HCL]
Hospices Civils de Lyon (HCL)
Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon
Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN)
Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
Services de Pneumologie, Exploration Fonctionnelle Respiratoire et Cardiologie (Hôpital Louis Pradel)
CarMeN, laboratoire
Source :: JAMA Cardiology, JAMA Cardiology, American Medical Association 2022, 7 (1), pp.112-113. ⟨10.1001/jamacardio.2021.4398⟩
Publication Year :: 2022
Publisher :: HAL CCSD, 2022.
Abstract: International audience; No abstract available

Subjects :: medicine.medical_specialty
business.industry
[SDV]Life Sciences [q-bio]
Myocardial Infarction
Disease
medicine.disease
[SDV] Life Sciences [q-bio]
Internal medicine
Time course
Key (cryptography)
medicine
Cardiology
Humans
Myocardial infarction
Cardiology and Cardiovascular Medicine
business
Biomarkers

Language :: English
ISSN :: 23806583 and 23806591
Database :: OpenAIRE
Journal :: JAMA Cardiology, JAMA Cardiology, American Medical Association 2022, 7 (1), pp.112-113. ⟨10.1001/jamacardio.2021.4398⟩
Accession number :: edsair.doi.dedup.....892f388bffd6d732afb17cc421be8bb6

Tools